Bita Esmaeli
Impact in
- Ophthalmology top 0.05%
- Ocular Oncology and Treatments
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
Papers in
- Ophthalmology 239
- Ocular Oncology and Treatments 201
- Nasolacrimal Duct Obstruction Treatments 42
- Drug-Induced Ocular Toxicity 20
-
- Lymphoma Diagnosis and Treatment 32
- Co-authors
- Moloud Ahmadi (23 shared papers)Victor Gerardo Prieto (27 shared papers)Gabriel N. Hortobágyi (6 shared papers)Vicente Valero (9 shared papers)Vivian T. Yin (19 shared papers)Edgardo Rivera (6 shared papers)Matthew C. Sniegowski (16 shared papers)Margaret L. Pfeiffer (12 shared papers)
- Journals
- Ophthalmic Plastic and Reconstructive Surgery (79 papers)Ophthalmology (23 papers)British Journal of Ophthalmology (16 papers)Head & Neck (14 papers)Cell Reports (12 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Bita Esmaeli
341 papers receiving 35k citations
Bita Esmaeli's Hit Papers
Peers
Comparison fields: 5 of 159
- Ophthalmology 6.1k
- Cancer Research 6.9k
- Oncology 8.5k
- Molecular Biology 7.7k
- Pulmonary and Respiratory Medicine 3.8k
Countries citing papers authored by Bita Esmaeli
This map shows the geographic impact of Bita Esmaeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bita Esmaeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bita Esmaeli more than expected).
Fields of papers citing papers by Bita Esmaeli
This network shows the impact of papers produced by Bita Esmaeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bita Esmaeli. The network helps show where Bita Esmaeli may publish in the future.
Co-authors
The 25 scholars most cited alongside Bita Esmaeli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 359 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Immune Landscape of Cancer Hit paper breakdown → | 2018 | 4385 |
| 2 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2633 |
| 3 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2371 |
| 4 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1758 |
| 5 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1748 |
| 6 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1634 |
| 7 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 824 |
| 8 | Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images Hit paper breakdown → | 2018 | 771 |
| 9 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 768 |
| 10 | Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma Hit paper breakdown → | 2017 | 726 |
| 11 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 696 |
| 12 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 617 |
| 13 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 598 |
| 14 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 580 |
| 15 | Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. | 2002 | 555 |
| 16 | 2002 | 475 | |
| 17 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers Hit paper breakdown → | 2018 | 470 |
| 18 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers Hit paper breakdown → | 2018 | 457 |
| 19 | The Immune Landscape of Cancer Hit paper breakdown → | 2019 | 455 |
| 20 | Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas Hit paper breakdown → | 2018 | 431 |
About Bita Esmaeli
Bita Esmaeli is a scholar working on Ophthalmology, Pathology and Forensic Medicine, Dermatology, Oncology and Epidemiology, having authored 359 papers that have together received 35.9k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (201 papers), Nasolacrimal Duct Obstruction Treatments (42 papers), Nonmelanoma Skin Cancer Studies (36 papers), Lymphoma Diagnosis and Treatment (32 papers), Cancer and Skin Lesions (21 papers), Drug-Induced Ocular Toxicity (20 papers), Reconstructive Facial Surgery Techniques (18 papers) and Cancer Genomics and Diagnostics (17 papers). The work is most often cited by research in Ophthalmology (6.1k citations), Cancer Research (6.9k citations), Oncology (8.5k citations), Molecular Biology (7.7k citations) and Pulmonary and Respiratory Medicine (3.8k citations). Bita Esmaeli has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Moloud Ahmadi, Victor Gerardo Prieto, Gabriel N. Hortobágyi, Vicente Valero, Vivian T. Yin, Edgardo Rivera, Matthew C. Sniegowski, Margaret L. Pfeiffer, Daniel J. Booser and Roxana Diba. Their work appears in journals such as Ophthalmic Plastic and Reconstructive Surgery, Ophthalmology, British Journal of Ophthalmology, Head & Neck and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.